review article | Q7318358 |
scholarly article | Q13442814 |
P356 | DOI | 10.1111/DOM.12400 |
P698 | PubMed publication ID | 25308775 |
P50 | author | Abd A. Tahrani | Q38362198 |
P2093 | author name string | A H Barnett | |
Q-A Altaf | |||
P2860 | cites work | Reduction in the Incidence of Type 2 Diabetes with Lifestyle Intervention or Metformin | Q22250892 |
Impact of sleep debt on metabolic and endocrine function | Q23731787 | ||
Circadian misalignment augments markers of insulin resistance and inflammation, independently of sleep loss | Q23919884 | ||
Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): prospective observational study | Q24652963 | ||
Adverse metabolic and cardiovascular consequences of circadian misalignment | Q24656239 | ||
Melatonin secretion and the incidence of type 2 diabetes | Q27277216 | ||
Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance | Q28186874 | ||
FXR is a molecular target for the effects of vertical sleeve gastrectomy | Q28236848 | ||
Potential role and therapeutic interests of myo-inositol in metabolic diseases | Q28292692 | ||
Apelin stimulates glucose utilization in normal and obese insulin-resistant mice | Q28302298 | ||
Partial sleep restriction decreases insulin sensitivity in type 1 diabetes | Q28396396 | ||
The fat-derived hormone adiponectin reverses insulin resistance associated with both lipoatrophy and obesity | Q28506782 | ||
Disruption of the Circadian Clock in Mice Increases Intestinal Permeability and Promotes Alcohol-Induced Hepatic Pathology and Inflammation | Q28534128 | ||
Molecular cloning of rat SH2-containing inositol phosphatase 2 (SHIP2) and its role in the regulation of insulin signaling | Q28581883 | ||
The lipid phosphatase SHIP2 controls insulin sensitivity | Q28584843 | ||
Obesity, gut hormones, and bariatric surgery. | Q37511828 | ||
Metabolism and circadian rhythms--implications for obesity | Q37621141 | ||
Bariatric surgery and taste: novel mechanisms of weight loss. | Q37630305 | ||
Glycaemic control in type 2 diabetes: targets and new therapies | Q37636745 | ||
Roux-en-Y gastric bypass vs intensive medical management for the control of type 2 diabetes, hypertension, and hyperlipidemia: the Diabetes Surgery Study randomized clinical trial. | Q37638200 | ||
Sympathetic nervous activation in obesity and the metabolic syndrome--causes, consequences and therapeutic implications. | Q37695713 | ||
The beta-cell in human type 2 diabetes. | Q37706253 | ||
Aerobic exercise and weight loss reduce vascular markers of inflammation and improve insulin sensitivity in obese women | Q37707072 | ||
Insulin resistance. A multifaceted syndrome responsible for NIDDM, obesity, hypertension, dyslipidemia, and atherosclerotic cardiovascular disease | Q37742798 | ||
Management of type 2 diabetes: new and future developments in treatment | Q37894446 | ||
11beta-Hydroxysteroid dehydrogenase type 1 inhibitors: novel agents for the treatment of metabolic syndrome and obesity-related disorders? | Q38015005 | ||
Mechanisms of weight loss, diabetes control and changes in food choices after gastrointestinal surgery. | Q38045816 | ||
Overexpression of 11beta-hydroxysteroid dehydrogenase-1 in adipose tissue is associated with acquired obesity and features of insulin resistance: studies in young adult monozygotic twins | Q45050580 | ||
Sibutramine improves fat distribution and insulin resistance, and increases serum adiponectin levels in Korean obese nondiabetic premenopausal women. | Q45162841 | ||
Type 2 diabetes, glycemic control, and continuous positive airway pressure in obstructive sleep apnea | Q45287871 | ||
Improvement in glucose metabolism after bariatric surgery: comparison of laparoscopic Roux-en-Y gastric bypass and laparoscopic sleeve gastrectomy: a prospective randomized trial. | Q45917277 | ||
Circadian rhythms of GIP and GLP1 in glucose-tolerant and in type 2 diabetic patients after biliopancreatic diversion | Q46116312 | ||
Inhibition of HDAC3 as a strategy for developing novel diabetes therapeutics | Q46155945 | ||
Jejunal nutrient sensing is required for duodenal-jejunal bypass surgery to rapidly lower glucose concentrations in uncontrolled diabetes. | Q46168291 | ||
Effect of vanadium on insulin sensitivity in patients with impaired glucose tolerance. | Q46228724 | ||
Metabolic risk factors in formerly obese women--effects of a pronounced weight loss by gastric band operation compared with weight loss by diet alone | Q46422658 | ||
Diabetes-induced renal vascular dysfunction is normalized by inhibition of epidermal growth factor receptor tyrosine kinase. | Q46508745 | ||
Muraglitazar, a dual (alpha/gamma) PPAR activator: a randomized, double-blind, placebo-controlled, 24-week monotherapy trial in adult patients with type 2 diabetes | Q46731741 | ||
Autonomic nervous system activity in diabetic and healthy obese female subjects and the effect of distinct weight loss strategies. | Q46766572 | ||
The Indian Diabetes Prevention Programme shows that lifestyle modification and metformin prevent type 2 diabetes in Asian Indian subjects with impaired glucose tolerance (IDPP-1). | Q46878587 | ||
Resveratrol, a red wine antioxidant, possesses an insulin-like effect in streptozotocin-induced diabetic rats | Q46910051 | ||
Efficacy, safety and tolerability of tesaglitazar when added to the therapeutic regimen of poorly controlled insulin-treated patients with type 2 diabetes | Q46973474 | ||
The effect of continuous positive airway pressure treatment on insulin sensitivity in patients with obstructive sleep apnoea syndrome and type 2 diabetes | Q47983895 | ||
U-shaped association of sleep duration with metabolic syndrome and insulin resistance in patients with type 2 diabetes: the Fukuoka Diabetes Registry | Q48132336 | ||
Sleep apnoea syndrome and 10-year cardiovascular risk in females with type 2 diabetes: relationship with insulin secretion and insulin resistance | Q48202771 | ||
Associations of chronotype and sleep with cardiovascular diseases and type 2 diabetes | Q48202905 | ||
Sleep apnea and glucose metabolism: a long-term follow-up in a community-based sample | Q48249427 | ||
Obstructive sleep apnea syndrome is associated with some components of metabolic syndrome in nonobese adults | Q48297395 | ||
Increasing length of wakefulness and modulation of hypocretin-1 in the wake-consolidated squirrel monkey | Q48460311 | ||
Estimating cardiac autonomic activity during sleep: impedance cardiography, spectral analysis, and Poincaré plots | Q48606202 | ||
Effect of sleep deprivation on overall 24 h growth-hormone secretion | Q48710927 | ||
Effects of insufficient sleep on blood pressure in hypertensive patients: a 24-h study | Q48770123 | ||
Prevention of type 2 (non-insulin-dependent) diabetes mellitus by diet and physical exercise. The 6-year Malmö feasibility study | Q50546299 | ||
Long-term longitudinal study on the relationship between alternating shift work and the onset of diabetes mellitus in male Japanese workers. | Q50781903 | ||
Lower ghrelin levels and exaggerated postprandial peptide-YY, glucagon-like peptide-1, and insulin responses, after gastric fundus resection, in patients undergoing Roux-en-Y gastric bypass: a randomized clinical trial. | Q51352550 | ||
Effects of 1-year orlistat treatment compared to placebo on insulin resistance parameters in patients with type 2 diabetes. | Q51369967 | ||
Insulin sensitivity and atherosclerosis. The Insulin Resistance Atherosclerosis Study (IRAS) Investigators. | Q51581413 | ||
Effects of D-chiroinositol added to a meal on plasma glucose and insulin in hyperinsulinemic rhesus monkeys. | Q54158115 | ||
Resveratrol improves insulin sensitivity, reduces oxidative stress and activates the Akt pathway in type 2 diabetic patients. | Q54606528 | ||
Discovery of a Small Molecule Insulin Mimetic with Antidiabetic Activity in Mice | Q58449888 | ||
Rotating night shift work and risk of type 2 diabetes: two prospective cohort studies in women | Q28741820 | ||
Lifestyle, diabetes, and cardiovascular risk factors 10 years after bariatric surgery | Q29614192 | ||
Mechanisms linking obesity to insulin resistance and type 2 diabetes | Q29614887 | ||
Effects of diet and exercise in preventing NIDDM in people with impaired glucose tolerance. The Da Qing IGT and Diabetes Study | Q29615122 | ||
Brief communication: Sleep curtailment in healthy young men is associated with decreased leptin levels, elevated ghrelin levels, and increased hunger and appetite | Q29615447 | ||
Leptin levels are dependent on sleep duration: relationships with sympathovagal balance, carbohydrate regulation, cortisol, and thyrotropin | Q29616274 | ||
The pathobiology of diabetic complications: a unifying mechanism | Q29617766 | ||
Circadian integration of metabolism and energetics | Q29619638 | ||
Mechanisms for insulin resistance: common threads and missing links | Q29620447 | ||
New advances in models and strategies for developing anti-obesity drugs | Q30429816 | ||
Obstructive sleep apnea in young lean men: impact on insulin sensitivity and secretion | Q30447694 | ||
Role of sleep and sleep loss in hormonal release and metabolism | Q30476176 | ||
Bariatric surgery: a systematic review and meta-analysis | Q30769299 | ||
Discovery of a small molecule insulin receptor activator | Q32120094 | ||
Calorie Restriction-like Effects of 30 Days of Resveratrol Supplementation on Energy Metabolism and Metabolic Profile in Obese Humans | Q32774312 | ||
Bariatric surgery versus intensive medical therapy for diabetes--3-year outcomes | Q33746480 | ||
Circadian control of glucose metabolism. | Q33766028 | ||
PTEN mutations as a cause of constitutive insulin sensitivity and obesity. | Q33811688 | ||
Sleep deprivation effects on the activity of the hypothalamic-pituitary-adrenal and growth axes: potential clinical implications | Q33872668 | ||
Activation of protein kinase C isoforms and its impact on diabetic complications | Q33881442 | ||
Neural basis of alertness and cognitive performance impairments during sleepiness. I. Effects of 24 h of sleep deprivation on waking human regional brain activity. | Q33928649 | ||
The 11-beta-hydroxysteroid dehydrogenase type 1 inhibitor INCB13739 improves hyperglycemia in patients with type 2 diabetes inadequately controlled by metformin monotherapy | Q33932723 | ||
Insulin-stimulated hydrogen peroxide reversibly inhibits protein-tyrosine phosphatase 1b in vivo and enhances the early insulin action cascade | Q33942025 | ||
The effects of extended bedtimes on sleep duration and food desire in overweight young adults: a home-based intervention | Q33956326 | ||
Insulin resistance and cardiovascular disease | Q34011027 | ||
Bariatric surgery and prevention of type 2 diabetes in Swedish obese subjects | Q34033254 | ||
Cortisol metabolism and the role of 11beta-hydroxysteroid dehydrogenase | Q34084865 | ||
Recent advances in the discovery of competitive protein tyrosine phosphatase 1B inhibitors for the treatment of diabetes, obesity, and cancer | Q34087341 | ||
Epidemiology of obstructive sleep apnea: a population health perspective | Q34126856 | ||
Leptin reverses insulin resistance and hepatic steatosis in patients with severe lipodystrophy | Q34129374 | ||
Effects of continuous positive airway pressure on glycemic control and insulin resistance in patients with obstructive sleep apnea: a meta-analysis | Q34192476 | ||
The impact of effective continuous positive airway pressure on homeostasis model assessment insulin resistance in non-diabetic patients with moderate to severe obstructive sleep apnea | Q34227968 | ||
Bariatric surgery versus conventional medical therapy for type 2 diabetes | Q34263754 | ||
11β-Hydroxysteroid dehydrogenase type 1 (11β-HSD1) inhibitors still improve metabolic phenotype in male 11β-HSD1 knockout mice suggesting off-target mechanisms | Q34316507 | ||
Meta-analysis: continuous positive airway pressure improves insulin resistance in patients with sleep apnea without diabetes | Q34340704 | ||
Effect of muraglitazar on death and major adverse cardiovascular events in patients with type 2 diabetes mellitus | Q34461583 | ||
Role of leptin and adiponectin in insulin resistance | Q38069779 | ||
Non-peptidyl insulin mimetics as a potential antidiabetic agent | Q38100566 | ||
11β-HSD1 inhibitors for the treatment of type 2 diabetes and cardiovascular disease | Q38132710 | ||
Cellular and molecular mechanisms of endothelial dysfunction in diabetes | Q38134022 | ||
Obstructive sleep apnoea and diabetes: an update | Q38139184 | ||
SIRT1 metabolic actions: Integrating recent advances from mouse models | Q38190964 | ||
Interactions between sleep, circadian function, and glucose metabolism: implications for risk and severity of diabetes | Q38195883 | ||
Circadian rhythms, insulin action, and glucose homeostasis | Q38210370 | ||
Specific inhibition of PTEN expression reverses hyperglycemia in diabetic mice | Q38290824 | ||
Rimonabant ameliorates insulin resistance via both adiponectin-dependent and adiponectin-independent pathways | Q38359027 | ||
Reduction of protein tyrosine phosphatase 1B increases insulin-dependent signaling in ob/ob mice | Q38359290 | ||
Adjustable gastric banding and conventional therapy for type 2 diabetes: a randomized controlled trial | Q38392749 | ||
Association of bariatric surgery with long-term remission of type 2 diabetes and with microvascular and macrovascular complications | Q38428629 | ||
High-dose resveratrol treatment for 2 weeks inhibits intestinal and hepatic lipoprotein production in overweight/obese men. | Q38443882 | ||
Gastric bypass vs sleeve gastrectomy for type 2 diabetes mellitus: a randomized controlled trial | Q38494463 | ||
Global estimates of diabetes prevalence for 2013 and projections for 2035. | Q39231145 | ||
The relationship between breakfast skipping, chronotype, and glycemic control in type 2 diabetes | Q39339317 | ||
A novel hydroxyfuroic acid compound as an insulin receptor activator. Structure and activity relationship of a prenylindole moiety to insulin receptor activation | Q39535230 | ||
The effect of continuous positive airway pressure on glucose control in diabetic patients with severe obstructive sleep apnea. | Q39735999 | ||
Effect of continuous positive airway pressure therapy on cardiovascular risk factors in patients with type 2 diabetes and obstructive sleep apnea. | Q40061787 | ||
Signaling Effects of Demethylasterriquinone B1, a Selective Insulin Receptor Modulator | Q40648668 | ||
Activation of insulin signal transduction pathway and anti-diabetic activity of small molecule insulin receptor activators | Q40750338 | ||
Insulin-like effect of pinitol | Q40859886 | ||
Early enhancements of hepatic and later of peripheral insulin sensitivity combined with increased postprandial insulin secretion contribute to improved glycemic control after Roux-en-Y gastric bypass | Q42449157 | ||
Effect of CPAP on insulin resistance and HbA1c in men with obstructive sleep apnoea and type 2 diabetes | Q42764571 | ||
Effects of one year treatment of sibutramine on insulin resistance parameters in type 2 diabetic patients. | Q42796380 | ||
A novel IKKbeta inhibitor stimulates adiponectin levels and ameliorates obesity-linked insulin resistance | Q42825735 | ||
A novel small molecule that directly sensitizes the insulin receptor in vitro and in vivo | Q42830170 | ||
Anti-diabetic and anti-adipogenic effects of a novel selective 11β-hydroxysteroid dehydrogenase type 1 inhibitor in the diet-induced obese mice | Q42833043 | ||
Thiazolidinedione derivatives as PTP1B inhibitors with antihyperglycemic and antiobesity effects | Q43270770 | ||
Superior weight loss and lower HbA1c 3 years after duodenal switch compared with Roux-en-Y gastric bypass--a randomized controlled trial | Q43474000 | ||
Intensive lifestyle changes are necessary to improve insulin sensitivity: a randomized controlled trial | Q43903128 | ||
The impact of sleep apnea treatment on carbohydrate metabolism in patients with acromegaly. | Q44125240 | ||
Improvement in hepatic insulin sensitivity after Roux-en-Y gastric bypass in a rat model of obesity is partially mediated via hypothalamic insulin action | Q44218851 | ||
Selective inhibition of 11beta-hydroxysteroid dehydrogenase type 1 decreases blood glucose concentrations in hyperglycaemic mice | Q44219623 | ||
Effects of the 11 beta-hydroxysteroid dehydrogenase inhibitor carbenoxolone on insulin sensitivity in men with type 2 diabetes. | Q44273298 | ||
Local and systemic impact of transcriptional up-regulation of 11beta-hydroxysteroid dehydrogenase type 1 in adipose tissue in human obesity | Q44547601 | ||
Effects of vanadium (III, IV, V)-chlorodipicolinate on glycolysis and antioxidant status in the liver of STZ-induced diabetic rats | Q44591196 | ||
Effect of duodenal-jejunal exclusion in a non-obese animal model of type 2 diabetes: a new perspective for an old disease | Q44699316 | ||
Effects of moderate weight loss and orlistat on insulin resistance, regional adiposity, and fatty acids in type 2 diabetes | Q44705123 | ||
Obstructive sleep apnoea and the risk of type 2 diabetes: a meta-analysis of prospective cohort studies | Q44797062 | ||
Adverse effects of modest sleep restriction on sleepiness, performance, and inflammatory cytokines | Q44883229 | ||
PPARalpha and PPARgamma dual agonists for the treatment of type 2 diabetes and the metabolic syndrome | Q34566145 | ||
Effect of aleglitazar on cardiovascular outcomes after acute coronary syndrome in patients with type 2 diabetes mellitus: the AleCardio randomized clinical trial | Q34660831 | ||
A single night of sleep deprivation increases ghrelin levels and feelings of hunger in normal-weight healthy men. | Q34787461 | ||
Protein kinase C inhibition ameliorates functional endothelial insulin resistance and vascular smooth muscle cell hypersensitivity to insulin in diabetic hypertensive rats | Q35081129 | ||
Apelin and insulin resistance: another arrow for the quiver? | Q35166911 | ||
Metformin, heart failure, and lactic acidosis: is metformin absolutely contraindicated? | Q35981002 | ||
Bariatric surgery versus intensive medical therapy in obese patients with diabetes | Q36025669 | ||
Type 2 diabetes: principles of pathogenesis and therapy | Q36095054 | ||
Sleep loss: a novel risk factor for insulin resistance and Type 2 diabetes. | Q36287612 | ||
Resveratrol supplementation does not improve metabolic function in nonobese women with normal glucose tolerance | Q36392797 | ||
Grape resveratrol increases serum adiponectin and downregulates inflammatory genes in peripheral blood mononuclear cells: a triple-blind, placebo-controlled, one-year clinical trial in patients with stable coronary artery disease | Q36563015 | ||
The twentieth century struggle to decipher insulin signalling | Q36631664 | ||
Role of insulin resistance in endothelial dysfunction | Q36674069 | ||
High-dose resveratrol supplementation in obese men: an investigator-initiated, randomized, placebo-controlled clinical trial of substrate metabolism, insulin sensitivity, and body composition. | Q36720635 | ||
Treating insulin resistance: future prospects. | Q36806514 | ||
Pilot study of resveratrol in older adults with impaired glucose tolerance. | Q36895103 | ||
11β-Hydroxysteroid dehydrogenase blockade prevents age-induced skin structure and function defects | Q36967015 | ||
Modulation of glucocorticoid action and the treatment of type-2 diabetes | Q37022376 | ||
Metabolic effects of bariatric surgery in patients with moderate obesity and type 2 diabetes: analysis of a randomized control trial comparing surgery with intensive medical treatment | Q37022586 | ||
PTP1B and TC-PTP: regulators of transformation and tumorigenesis | Q37072449 | ||
Diagnosis of obstructive sleep apnea in adults | Q37077144 | ||
Chronotype is independently associated with glycemic control in type 2 diabetes | Q37106369 | ||
Very low-calorie diet mimics the early beneficial effect of Roux-en-Y gastric bypass on insulin sensitivity and β-cell Function in type 2 diabetic patients | Q37110587 | ||
Banting Lecture. From the triumvirate to the ominous octet: a new paradigm for the treatment of type 2 diabetes mellitus | Q37141727 | ||
Reduction in weight and cardiovascular disease risk factors in individuals with type 2 diabetes: one-year results of the look AHEAD trial | Q37151277 | ||
Short sleep duration measured by wrist actimetry is associated with deteriorated glycemic control in type 1 diabetes | Q37193527 | ||
Genetic dissection of type 2 diabetes | Q37322800 | ||
11beta-hydroxysteroid dehydrogenase type 1 regulates glucocorticoid-induced insulin resistance in skeletal muscle | Q37400786 | ||
Reduced sleep duration or quality: relationships with insulin resistance and type 2 diabetes | Q37403202 | ||
Role of resistin in insulin sensitivity in rodents and humans | Q37411522 | ||
Effects of Roux-en-Y gastric bypass or diabetes support and education on insulin sensitivity and insulin secretion in morbidly obese patients with type 2 diabetes | Q37445774 | ||
Association of obstructive sleep apnea in rapid eye movement sleep with reduced glycemic control in type 2 diabetes: therapeutic implications | Q37504129 | ||
P433 | issue | 4 | |
P921 | main subject | insulin resistance | Q1053470 |
type 2 diabetes | Q3025883 | ||
P304 | page(s) | 319-334 | |
P577 | publication date | 2014-11-12 | |
P1433 | published in | Diabetes, Obesity and Metabolism | Q5270109 |
P1476 | title | Novel therapeutics for type 2 diabetes: insulin resistance | |
P478 | volume | 17 |